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ABSTRACT
Objective: The aim of this study was to investigate the in-vitro hepatoprotective activity of solvent extracts of Albizia lebbeck, Cassia occidentalis, and 
Swertia chirata on HepG2 cell line.
Methods: The methanolic, ethanolic, and acetone seed extracts of A. lebbeck, C. occidentalis, and leaves extract of S. chirata were used in this study. The 
different extracts of A. lebbeck, C. occidentalis, and S. chirata were assessed for their hepatoprotective activity on human liver hepatocellular carcinoma 
(HepG2) cell line against paracetamol (PCM) as a liver damage inducing agent. The cell line viability was assessed by 3-(4,5-dimethyl thiazol-2-yl)-5-
diphenyltetrazolium bromide assay.
Results: The percentage cell viability was determined with respect to the normal control cells. Control cells showed 100% cell viability in all tested 
plant extracts. The PCM treated HepG2 cells showed a maximum cell viability (46.6±2.49%) in presence of all seed extracts of A. lebbeck. The silymarin 
and PCM treated HepG2 cells showed maximum cell viability (156.6±2.49%) presence of leaves extract of S. chirata. The maximum cells viability of 
131.6±9.39% was observed in methanolic seed extract of A. lebbeck (50 µg/mL), and the minimum cell viability of 107.3±3.68% was observed in 
acetone seed extract of C. occidentalis (50 µg/mL) comparatively.
Conclusions: The methanolic, ethanolic, and acetone extracts of seeds/leaves from A. lebbeck, C. occidentalis, and S. chirata were showed the 
hepatoprotective activity. Further in vivo and clinical studies are required to confirm their therapeutic efficacy.
Keywords: Albizia lebbeck, Cassia occidentalis, Swertia chirata, Paracetamol, HepG2, [3-(4,5-dimethyl thiazol-2-yl)-5-diphenyltetrazolium bromide] 
assay.
INTRODUCTION
Herbal medicines have the ability to affect body systems. The effects 
are dependent on the chemical constituents present in the plant used. 
Scientists first started extracting and isolating chemicals from plants 
in the 18th century and since that time, we have grown a custom of 
looking at herbs and their effects in terms of the active constituents they 
contain. Albizia lebbeck (Shirish, Leguminosae) is a deciduous tree with 
compound leaves, flat an oblong fruit, round cream colored seeds, and 
grows wild. The plant is found throughout India, Bangladesh, tropical 
and subtropical Asia, and Africa [1,2]. Therapeutically bark is used in 
bronchitis; bark and seeds in piles; root in hemicranias; flowers in a 
cough, bronchitis, tropical pulmonary eosinophilia, and asthma [3]. 
The seeds contain e-chinocystic acid and β-sitotosteroland quercetin. 
It has been reported that A. lebbeck has antibacterial, analgesic, anti-
inflammatory, antioxidant, anti-asthmatic and anti-anaphylactic, 
nootropic, anxiolytic and anticonvulsant activities [4]. Swertia chirata, 
Indian name: Chirayata (Gentianaceae) is a robust annual herb which 
grows up to about 1.5 meters in height. It has leaves in opposite 
pair about 10 cm long, without stalks, pointed at the tip. The plant 
has numerous flowers, pale green in color, tinged with purple, with 
long white or pink hairs and minute sharp pointed fruits. The whole 
plant, collected in its flowering stage and dried, constitutes the drug. 
It is found in the Himalayan ranges of India from Kashmir to Bhutan 
at an altitude of 1200-3000 m. It is also found in the Khasi Hills of 
Meghalaya at an altitude of 1200-1500 m [5]. It has long been used by 
the Ayurvedic physicians as a bitter tonic. The plant contains a bitter 
glycoside chiratin, which yields on hydrolysis, two bitter principles, 
ophelic acid and chiratin. The ophelic acid is a brown hydroscopic 
substance which is soluble in water and alcohol. Chirata is an effective 
drug for reducing fever [6]. It has been widely used as herbal medicine 
in Asian countries particularly in India, Nepal, Myanmar, Arab and 
some parts of the European countries. Reported studies showed 
extracts of this plant has attributable properties as hypoglycemic, 
antipyretic, anti-inflammatory, antibacterial, antiviral, antimalarial, 
antihepatotoxic, and wound healing activity [7]. Cassia occidentalis 
belongs to the genus Cassia and the Family Caesalpiniaceae. It is called 
Stinking Weed. In Hausa, it is known as “Rai dore.” In Igbo, it is called 
“Osiisi” while “Gaya” in Nupe [8]. It is an erect herb, commonly found by 
road sides, ditches and waste dumping sites. C. occidentalis has many 
applications in traditional medicine. All the parts of the plant have 
medicinal uses. Traditionally, its roots, leaves, flowers and seeds are 
used as laxatives and purgative. Phytochemically, the aqueous extract 
of C. occidentalis contains tannins, anthraquinone, sterol, cardiac 
glycosides, saponin, and alkaloids. The World Health Organization 
estimated that 80% of the population of developing countries relies 
on traditional medicines, mostly plant drugs, for their primary health 
care needs. Medicinal plants play an important role in the discovery 
of novel drugs used in modern medicine [9]. Traditional medicines 
have been used for many centuries by a substantial proportion of the 
population of India. India has a rich heritage of traditional knowledge 
and is home to several important time-honored systems of health 
care like Ayurveda, Siddha, and Unani. It has been estimated that the 
proportion of medicinal plants in India (7,500 of the 17,000 higher 
plant species are medicinal plants) is higher than any country of the 
world with respect to the existing flora of that respective country 
[10]. There are a number of studies which highlight the uses of herbal 
drugs using the plant extracts of S. chirata, Albizia, and Andrographis 
paniculata to name a few in hepatoprotection [11,12]. These 
observations have drawn attention for the present study which is an 
attempt to explore the in-vitro hepatoprotective activity of seeds of 
A. lebbeck and C. occidentalis and leaves of S. chirata on human liver 
hepatocellular carcinoma cells.
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METHODS
Collection and preparation of the plants extracts
A. lebbeck and C. occidentalis were collected from the area of Nakronda 
forest range, (30°14’19.60”N, 78°07’01.70”E), Dehradun, and S. chirata 
was collected from Chobattakhal (29°57’16.40”N, 78°52’41.20”E), 
Pauri Garhwal, Uttarakhand region of North India. The above-
mentioned plants were examined, identified, and authenticated. The 
seeds of A. lebbeck, C. occidentalis, and leaves of S. chirata were air 
dried and pulverized into powder. About 30 g of the powdered sample 
of each medicinal plant were weighed and extracted in 100 mL each 
of methanol (ME), ethanol (ET) and acetone (AC) extract in a soxhlet 
apparatus separately and the process is carried out for 7 days at 
40-45°C. The filtrate was evaporated to dryness at 40°C in a rotary 
evaporator. The above process was repeated for several times until the 
sufficient amount of extract is produced. The concentrated extract of 
each plant was stored at 4°C until when required for use.
Chemicals
3-(4,5-dimethyl thiazol-2-yl)-5-diphenyltetrazolium bromide (MTT), 
fetal bovine serum (FBS), phosphate buffered saline (PBS), Dulbecco’s 
Modified Eagles Medium (DMEM), trypsin, ethylenediaminetetraacetic 
acid (EDTA), glucose, dimethyl sulfoxide, and hydrogen peroxide were 
obtained from Hi-Media Laboratories Ltd., Mumbai.
HepG2 cell line
Human liver hepatocellular carcinoma (HepG2) cell lines were 
obtained from the National Centre for Cell Science (NCCS) Pune, India. 
The cells were regularly maintained in DMEM containing 10% FBS in 
a humidified atmosphere of 5% CO2 at 37°C until confluent. The cells 
were dissociated with trypsin phosphate versene glucose solution 
(0.2% trypsin, 0.02% EDTA, 0.05% glucose in PBS). The stock cultures 
were grown in 25 cm2 culture flasks and all experiments were carried 
out in 96 microtiter plates (Tarsons India Pvt. Ltd., Kolkata, India). The 
cells were seeded at a density of 1×105 cells/mL. The culture medium 
was changed twice a week.
MTT assay
The cells were seeded at density of 1.0×105 cells/mL in 96-well flat 
bottomed plates, and incubated at 37°C in a humidified incubator 
with 5% CO2. After 24 hrs, when partial monolayer was formed, the 
supernatant was flicked off and the monolayer was washed once. The 
final volume of all the treated and the control wells was kept same, 
i.e., 500 µl. Paracetamol (PCM) (1%), silymarin, (100 µg/ml), different 
concentrations (100 µg/mL, 50 µg/mL, 25 µg/mL, 12.5 µg/mL) of 
methanolic, ethanolic and acetone extract of A. lebbeck, C. occidentalis 
and Swertia chirata were added to specified wells. The silymarin 
was used as a control. Microscopic examination was carried out 
after 60 minutes of PCM intoxification. Cytotoxicity was assessed by 
estimating the percentage viability of HepG2 cells by MTT reduction 
assay. The absorbance was measured by enzyme-linked immune sorbent 
assay‎ reader at 540 and 630 nm [13]. The wells containing medium 
only served as a blank while the wells containing untreated wells were 
used as a control in the assay. The test was performed in duplicates. The 
percentage cell viability was calculated using the formula.
Percent cell viability= 
Absorbance of treated cells
Absorbance of normal control cells
×100
Statistical analysis
The results of hepatoprotective activity were expressed as the 
mean±SEM. A statistical analysis was performed with one-way analysis 
of variance followed by Tukey’s multiple comparison tests using Graph 
Pad Instat Software. p<0.05 was considered to be statistically significant 
(p<0.05).
RESULTS
The percentage cell viability with respect to the normal control (NC) cell 
lines (HepG2) at different concentrations of methanolic, ethanolic and 
acetone seeds extracts of A. lebbeck, C. occidentalis and leaves of S. chirata 
were determined. The NC cells showed 100±0.02% cell viability in all 
tested plant samples (Fig. 1). The PCM treated HepG2 cells showed 
46.6±2.49% cell viability in all extracts of A. lebbeck; 44.3±1.69% cell 
viability in all extracts of C. occidentalis and 46.3±1.24% cell viability 
in all extracts of S. chirata (Fig. 2). The silymarin and PCM treated 
HepG2 cells showed 156.3±1.69% cell viability in all extracts of 
A. lebbeck; 154±1.63% cell viability in all extracts of C. occidentalis and 
156.6±2.49% cell viability in all extracts of S. chirata (Fig. 3).
The methanolic seed extract of A. lebbeck at concentration 
100 µg/mL, 50 µg/mL, 25 µg/mL and 12.5 µg/mL showed 
140.6±1.69%, 154.3±5.90%, 105.3±2.49%, 87.6±4.02% cell viability, 
respectively. The ethanolic seed extract of A. lebbeck at concentration 
100 µg/mL, 50 µg/mL, 25 µg/mL and 12.5 µg/mL showed 
134±3.74%, 147.6±3.85%, 100±4.32%, 79.3±1.88% cell viability, 
respectively. The acetone seed extract of A. lebbeck at concentration 
100 µg/mL, 50 µg/mL, 25 µg/mL and 12.5 µg/mL showed 123.3±7.36%, 
136.6±7.71%, 94±5.09%, 79.6±5.43% cell viability, respectively. Out of 
all, 50 µg/mL concentration was selected for checking its protective 
efficacy in presence of PCM. 50 µg/mL methanolic extract (ME) and 
PCM showed 131.6±9.39% cell protection, 50 µg/mL ethanolic extract 
(ET) and PCM showed 120.3±7.03% cell protection and 50 µg/mL AC 
and PCM showed 115.3±8.37% cell protection (Figs. 4a and 5).
Fig. 1: Normal control cells. The HepG2 cells pretreated with 
Dulbecco’s Modified Eagles Medium showing normal cells surface 
architecture (×40)
Fig. 2: Paracetamol (PCM) treated. PCM induced toxicity to hepatic 
cells (HepG2) showed detachment of cells from the surface of 
plate, rounding up of cells and alteration in cellular meshwork 
indicating cytotoxicity and necrosis (×40)
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100 µg/mL, 50 µg/mL, 25 µg/mL and 12.5 µg/mL showed 119±7.87%, 
134.6±8.9%, 90.3±10.3%, 71.3±7.71% cell viability, respectively. 
Out of all, 50 µg/mL concentration was selected for checking its 
protective efficacy in presence of PCM. 50 µg/mL ME and PCM showed 
120±2.44% cell protection, 50 µg/mL ET and PCM showed 117±1.63% 
cell protection and 50 µg/mL AC and PCM showed 110±1.63% cell 
protection (Figs. 4c, 7 and Table 1).
DISCUSSION
Medicinal plants are crucial for about 80% of the world population in 
developing as well as the developed nations for their primary and basic 
health care needs owing to better tolerability, superior compatibility 
with human body and having lesser side effects. The herbal drugs are 
rapidly becoming popular due to the study of the extensive activity of 
different plant components and their therapeutic principles [14].
Among the plant species, A. lebbeck, C. occidentalis and S. chirata also 
seem to possess numerous pharmacological properties. Bioactive 
compounds such as saponins, alkaloids, flavonoids, and phenolic 
compounds are reported to be highly active against cytotoxicity in 
tumor cancer cells. They are widely used as anti-asthma, anti-septic, 
Fig. 3: Silymarin treated. HepG2 cells pretreated with silymarin 
(hepatoprotective drug), at concentration of 100 µg/mL showed 
intact cells and a confluent meshwork of cells (×40)
Fig. 5: Cell cytotoxicity assay (3-(4,5-dimethyl thiazol-2-yl)-5-
diphenyltetrazolium bromide assay) of Albizia lebbeck seed 
extract. Percentage cell viability of NC, paracetamol (PCM) 
treated, silymarin treated, ME, ME, ET and AC (at different 
concentrations), test extract (50 µg/mL) with PCM in respect 
to normal cell control (HepG2 cell). NC: Normal control, 
ME: Methanolic extract, ET: Ethanolic extract, AC: Acetone extract
Fig. 6: Cell cytotoxicity assay (3-(4,5-dimethyl thiazol-2-yl)-
5-diphenyltetrazolium bromide assay) of Cassia occidentalis 
seed extract. Percentage cell viability of NC, paracetamol 
(PCM) treated, silymarin treated, ME, ET and AC (at different 
concentrations), test extract (50 µg/mL) with PCM in respect 
to normal cell control (HepG2 cell). NC: Normal control, 
ME: Methanolic extract, ET: Ethanolic extract, AC: Acetone extract
The methanolic seed extract of C. occidentalis at concentration 
100 µg/mL, 50 µg/mL, 25 µg/mL and 12.5 µg/mL showed 
136.6±5.31%, 147.3±4.98%, 100.3±4.92%, 81.3±7.40% cell 
viability respectively. The ethanolic seed extract of C. occidentalis at 
concentrations 100 µg/mL, 50 µg/mL, 25 µg/mL and 12.5 µg/mL 
showed 123.3±6.79%, 145.6±3.09%, 97.6±7.84%, 78.3±9.28% cell 
viability respectively. The acetone seed extract of C. occidentalis at 
concentrations 100 µg/mL, 50 µg/mL, 25 µg/mL and 12.5 µg/mL 
showed 99.6±5.90%, 128.6±11.4%, 87.3±6.54%, 68.6±5.24% cell 
viability respectively. Out of all, 50 µg/mL concentration was selected 
for checking its protective efficacy in presence of PCM. 50 µg/mL ME 
and PCM showed 114.3±6.34% cell protection, 50 µg/mL ET and 
PCM showed 113.6±3.29% cell protection and 50 µg/mL AC and PCM 
showed 107.3±3.68% cell protection (Figs. 4b and 6).
The methanolic leave extract of S. chirata at concentration 
100 µg/mL, 50 µg/mL, 25 µg/mL and 12.5 µg/mL showed 
134.6±6.23%, 149.6±7.03%, 106.6±9.56%, 85.3±6.18% cell viability, 
respectively. The ethanolic leaves extract of S. chirata at concentrations 
100 µg/mL, 50 µg/mL, 25 µg/mL and 12.5 µg/mL showed 
120.6±8.05%, 144.3±3.09%, 108.6±10.6%, 71±5.71% cell viability, 
respectively. The acetone leaves extract of S. chirata at concentrations 
Fig. 4: Pretreatment with plant extracts (50 µg/mL). 
(a) Protection of HepG2 pre-treated with methanolic extract 
(ME) of Albizia lebbeck seed, (b) protection of HepG2 pre-treated 
with ME of Cassia occidentalis seed, (c) protection of HepG2 pre-
treated with ME of Swertia chirata leaves (×40)
a b
c
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anti-dysenteric, anti-tubercular, antioxidant and anti-microbial agents 
and also possess hepatoprotective activity [10,15]. In-vitro bioassays 
of biological extracts possessing >200 μg/mL are not considered 
meaningful as it is unlikely that such concentrations will be reached in-
vivo and due to the probability that high concentrations of plant extracts 
will significantly change the physiochemical environment in terms of 
ionic strength, pH and osmolarity which will impact the cell viability 
independent of the extract itself leading to artificial toxicity [16,17]. 
Therefore keeping in mind this fact, this study used a maximum 
concentration of 100 µg/mL of the plant extracts in all the experiments.
In this study, we evaluated the hepatoprotective activity of methanol, 
ethanol and ACs of seeds from A. lebbeck, C. occidentalis and leaves 
extract from S. chirata against PCM induced cytotoxicity. Incubating 
HepG2 cells with PCM for 2 hrs caused a significant loss in the cell 
viability. Pretreatment with methanolic, ethanolic and ACs of the 
above-mentioned plants for the same time interval resulted in a dose-
dependent increase in cell viability at concentrations ranging from 12.5 
to 50 µg/mL and then after, an appreciable decrease at a concentration 
of 100 µg/mL. The highest percentage cell viability (154.3±5.90%) 
was observed at 50 µg/mL concentration of methanolic seed extract of 
A. lebbeck, therefore in the test treated group, this concentration was 
selected along with PCM. The treated group showed 131.6±9.39% cell 
viability confirming its heaptoprotective potential, while acetone seed 
extract of C. occidental is showed lowest cell viability (128.6±11.4%) at 
the same concentration (i.e., 50 µg/mL) and in test treated group it was 
observed 110±1.63% confirming its heaptoprotective potential. Further, 
on comparing with the reference standard where silymarin showed 
156.3±1.69% cell viability in seed extracts of A. lebbeck, 154±1.63% 
cell viability in seed extracts of C. occidentalis and 156.6±2.49% 
cell viability in leaves extract of S. chirata against PCM induced 
hepatotoxicity on HepG2 cell line. In a similar study by Drever et al., [18] 
it was shown that ET of C. species exhibit remarkable neuroprotection 
in mouse hippocampal cultures. Studies have promisingly shown 
hepatoprotection and immunomodulation by methanolic and ETs of 
A. lebbeck and S. chirata [6,19,20]. Promising results have also been 
shown in the model of Wister rats proving histologically the beneficial 
effect of the ET of A. lebbeck in hepatoprotection [21]. Our study also 
revealed the hepatoprotective activity of C. occidentalis.
Hence, overall results indicates that methanolic, ethanolic and acetone 
seed extracts of A. lebbeck, C. occidentalis and leaves extract of S. chirata 
possess a potent hepatoprotective activity against PCM induced hepatic 
damage, and the main mechanism involved in the protection could be 
associated with its strong capability to reduce the intracellular level 
of reactive oxygen species. The effective components which might act 
against oxidative damage are mainly phenolic compounds, flavonoids, 
and tannins [22]. Many phytochemical reports revealed that the ME of 
the plants was found to contain higher concentration of terpenoids in 
addition to flavonoids [23]. Elucidating the exact cellular mechanism of 
action of these plant extracts on hepatic cells is outside the scope of the 
present study, and it can only be speculated whether any or all of these 
extracts act at a common point involved in inhibiting distinct pathways 
involved in cell death. Indeed, the very nature of herbal extracts means 
it is impossible to attribute actions seen to specific compound, given the 
number of pharmacologically active substances in such preparations 
their potentially complex interaction. In addition, these extracts can 
also be tried as a combination therapy in-vivo and in-vitro to know 
and understand the synergistic action of these compounds if any, 
cellular protection. Our findings are relevant for future therapeutic 
considerations related to methanolic, ethanolic and ACs of these plants 
alone or in combination for hepatic disorders.
CONCLUSION
ME of A. lebbeck, C. occidentalis, and S. chirata showed the most 
efficient hepatoprotective activity against PCM on HepG2 cell lines 
with silymarin as control compared to ethanolic and AC of A. lebbeck, 
C. occidentalis and S. chirata, respectively. The above study indicates 
positive hepatoprotective activity of the above mentioned plants. 
Characterization and identification of active principles in ME of 
A. lebbeck are further required to evaluate its potential as a potent 
hepatoprotective agent for liver drug formulation. Further in-vivo and 
clinical studies are also required to confirm its therapeutic efficacy.
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